Femhrt and Arthropathy - a phase IV clinical study of FDA data

Summary:

Arthropathy is reported as a side effect among people who take Femhrt (ethinyl estradiol; norethindrone acetate), especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months also take Prilosec, and have Osteoporosis.

The phase IV clinical study analyzes which people have Arthropathy when taking Femhrt. It is created by eHealthMe based on reports of 1,924 people who have side effects when taking Femhrt from the FDA, and is updated regularly.

What is Femhrt?

Femhrt has active ingredients of ethinyl estradiol; norethindrone acetate. It is often used in menopause. eHealthMe is studying from 2,025 Femhrt users. Check the latest studies of Femhrt.

What is Arthropathy?

Arthropathy is found to be associated with 1,608 drugs and 1,682 conditions by eHealthMe. Check the latest studies of Arthropathy.

On Jul, 11, 2026

1,924 people reported to have side effects when taking Femhrt.
Among them, 19 people (0.99%) have Arthropathy.

Among these 19 people:

How long have people been on Femhrt when they have Arthropathy? *

What is the gender of people who have Arthropathy when taking Femhrt? *

female: 100 %
male: 0.0 %

What is the age of people who have Arthropathy when taking Femhrt? *

What are other drugs people take besides Femhrt? *

What are other side effects people have besides Arthropathy? *

Fall: 11 people, 57.89%
Stress And Anxiety: 9 people, 47.37%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 8 people, 42.11%
Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 7 people, 36.84%
Dental Caries: 7 people, 36.84%
Osteoporosis (bones weak and more likely to break): 7 people, 36.84%
Head Injury: 7 people, 36.84%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 7 people, 36.84%
Joint Pain: 6 people, 31.58%
Muscle Tightness: 5 people, 26.32%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 7 people, 36.84%
High Blood Pressure: 4 people, 21.05%
Polyarthritis (arthritis which involves 5 or more joints simultaneously): 4 people, 21.05%
Pain: 4 people, 21.05%
Osteopenia (a condition where bone mineral density is lower than normal): 4 people, 21.05%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 21.05%
Anaemia (lack of blood): 3 people, 15.79%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 15.79%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 15.79%
High Blood Cholesterol: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Femhrt and have Arthropathy?

- Check whether Arthropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Femhrt:

Femhrt (2,025 reports)

Arthropathy treatments and more:

Arthropathy (75,984 reports)

How severe was Arthropathy and when was it recovered:

Arthropathy in Femhrt

Expand to all the drugs that have ingredients of ethinyl estradiol; norethindrone acetate:

Arthropathy and drugs with ingredients of ethinyl estradiol; norethindrone acetate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Femhrt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arthropathy:

Arthropathy (1,608 drugs)

Browse all the conditions that are associated with Arthropathy:

Arthropathy (1,682 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norethindrone acetate (the active ingredients of Femhrt) and Femhrt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.